Home > Insider Trading > Filing (0000905148-24-003236)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1228627	Opus Genetics Inc.	IRD	Pharmaceutical Preparations (2834)	113516358

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1999390	George Magrath	C/O Opus Genetics, Inc. 37000 Grand River Ave, Suite 120 Farmington Hills MI 48335	Chief Executive Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-11-15	90,294	$1.01	483,244	No	4	P	Direct
Common Stock	Acquisiton	2024-11-18	9,706	$1.02	492,950	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

The price in column 4 represents the weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.975 to $1.05, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The price in column 4 represents the weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.005 to $1.06, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.